COMMUNIQUÉS West-GlobeNewswire

Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
01/02/2024
Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its Mini-Adductoplasty™ System and RedPoint™ Patient-Specific [...]
Panbela Announces Closing of Approximately $9.0 Million Public Offering
01/02/2024
MINNEAPOLIS, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today [...]
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
01/02/2024
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that one oral presentation and 11 posters across its development programs will be included at the 20th Annual [...]
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/02/2024
MOUNTAIN VIEW, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred [...]
Opthea Strengthens Team with Key Clinical and Regulatory Hires
01/02/2024
Dr. Julie Clark, SVP Clinical Development; Dr. Fang Li, SVP Regulatory Affairs, to join February 1st Experienced executives bring extensive track record in products for retinal and ophthalmology diseases MELBOURNE, [...]
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
01/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug [...]
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
01/02/2024
HYDERABAD, India, Feb. 01, 2024 (GLOBE NEWSWIRE) -- To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, [...]
HUTCHMED to Announce 2023 Final Results
01/02/2024
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December [...]
EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO
01/02/2024
GLASGOW, Scotland, Feb. 01, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage biopharmaceutical company with the premier platform for full-spectrum microbiome therapeutics, today announced the [...]
Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation
01/02/2024
Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation Newly appointed CEO, Dr Xavier Leroy, will lead GIO Therapeutics in [...]
Legacy Novozymes delivers solid last full-year results
01/02/2024
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial [...]
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024
01/02/2024
Genflow Biosciences Plc ("Genflow" or "the Company") LONDON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The Company (LSE:GENF) (OTCQB:GENFF), an emerging leader in the field of longevity research developing therapeutics that [...]
Michael Austwick Joins Verona Pharma as Non-Executive Director
01/02/2024
LONDON and RALEIGH, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”) announces Mr. Michael Austwick has today joined the board as a Non-Executive Director. Mr. Austwick brings a [...]
Results update for 2023 – unaudited
01/02/2024
6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual report now is expected to [...]
Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee
01/02/2024
François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee Paris, February 1, 2024 . François-Xavier Roger will be appointed Chief Financial Officer and a member of Sanofi’s Executive [...]
Communiqué de presse : François-Xavier Roger nommé Directeur Financier, membre du Comité exécutif de Sanofi
01/02/2024
François-Xavier Roger nommé Directeur Financier, membre du Comité exécutif de Sanofi Paris, 1er février, 2024 . François-Xavier Roger sera nommé Directeur Financier et membre du Comité Exécutif de Sanofi à compter du [...]
Press Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
01/02/2024
Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline Paris, February 1, 2024 Q4 2023 sales growth of 9.3% at CER and business EPS (1) [...]
Communique de presse - 2023 : Croissance des ventes et du bénéfice net par action à TCC, succès des lancements de produits et avancée du portefeuille R&D en Immunologie
01/02/2024
2023 : Croissance des ventes et du bénéfice net par action à TCC, succès des lancements de produits et avancée du portefeuille R&D en Immunologie Paris, le 1 février 2024 T4 2023 : Augmentation des ventes de 9,3% à [...]
Sandoz announces changes in the Board of Directors
01/02/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Graeme Pitkethly nominated as candidate for election to the Sandoz Board of Directors at the upcoming Annual General Meeting [...]

Pages